Literature DB >> 28643197

AMPK is activated early in cerebellar granule cells undergoing apoptosis and influences VADC1 phosphorylation status and activity.

A Bobba1, E Casalino2, G Amadoro3, V A Petragallo4, A Atlante4.   

Abstract

The neurodegeneration of cerebellar granule cells, after low potassium induced apoptosis, is known to be temporally divided into an early and a late phase. Voltage-dependent anion channel-1 (VDAC1) protein, changing from the closed inactive state to the active open state, is central to the switch between the early and late phase. It is also known that: (i) VDAC1 can undergo phosphorylation events and (ii) AMP-activated protein kinase (AMPK), the sensor of cellular stress, may have a role in neuronal homeostasis. In the view of this, the involvement of AMPK activation and its correlation with VDAC1 status and activity has been investigated in the course of cerebellar granule cells apoptosis. The results reported in this study show that an increased level of the phosphorylated, active, isoform of AMPK occurs in the early phase, peaks at 3 h and guarantees an increase in the phosphorylation status of VDCA1, resulting in a reduced activity of this latter. However this situation is transient in nature, since, in the late phase, AMPK activation decreases as well as the level of phosphorylated VDAC1. In a less phosphorylated status, VDAC1 fully recovers its gating activity and drives cells along the death route.

Entities:  

Keywords:  AMPK; Apoptosis; Cerebellar granule cells; VDAC

Mesh:

Substances:

Year:  2017        PMID: 28643197     DOI: 10.1007/s10495-017-1389-8

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  3 in total

1.  Metabolic Alterations in Sputum and Exhaled Breath Condensate of Early Stage Non-Small Cell Lung Cancer Patients After Surgical Resection: A Pilot Study.

Authors:  Naseer Ahmed; Biniam Kidane; Le Wang; Zoann Nugent; Nataliya Moldovan; April McElrea; Shiva Shariati-Ievari; Gefei Qing; Lawrence Tan; Gordon Buduhan; Sadeesh K Srinathan; Renelle Meyers; Michel Aliani
Journal:  Front Oncol       Date:  2022-06-03       Impact factor: 5.738

Review 2.  Targeting AMPK by Statins: A Potential Therapeutic Approach.

Authors:  Sajad Dehnavi; Amirhossein Kiani; Mahvash Sadeghi; Ali Farhadi Biregani; Maciej Banach; Stephen L Atkin; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  Drugs       Date:  2021-05-03       Impact factor: 9.546

3.  Curcumin Acts as a Chemosensitizer for Leiomyosarcoma Cells In Vitro But Fails to Mediate Antioxidant Enzyme Activity in Cisplatin-Induced Experimental Nephrotoxicity in Rats.

Authors:  Irida Dhima; Stelios Zerikiotis; Panagiotis Lekkas; Yannis V Simos; Maria Gkiouli; Patra Vezyraki; Evangelia Dounousi; Vasilios Ragos; Xenophon Giannakopoulos; Dimitrios Baltogiannis; Vasiliki Kalfakakou; Angelos Evangelou; Dimitrios Peschos; Spyridon Karkabounas
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.